Skip to main content



Local Cdiff information for Michigan

Michigan

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.



Local Cdiff information for Michigan

Michigan

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.

Providers

Dr. Teena Chopra, MD, MPH

Professor, Infectious Diseases, Wayne State University; Corporate Medical Director of Infection Prevention and Hospital Epidemiology and Antibiotic Stewardship, DMC and WSU
Detroit Medical Center, Wayne State University
4201 St Antoine
Detroit, 48201
313-745-4210
EMAIL DR. CHOPRA >
FMT Provider: Yes
VISIT WEBSITE >

Dr. John Yung-Chong Kao, MD

Professor, Internal Medicine
Gastroenterology Clinic Taubman Center
1500 E Medical Center Dr
Floor 3, Reception D
Ann Arbor, 48109
(888) 229-7408
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 9470
Hospital Onset: 4546
Community Onset: 4924
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.75
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Brenda Brennan, MSPH
HAI Coordinator / SHARP Unit Manager, Surveillance for Healthcare-Associated and Resistant Pathogens (SHARP) Unit
Michigan Department of Health and Human Services
Capitol View Building, 5th floor
201 Townsend, 5th Floor
Lansing, 48913
(517) 284-4945
(517) 335-8263
EMAIL BRENDA BRENNAN, MSPH >

CLINICAL TRIALS

DSM 33864

Official Title: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Tolerability and Effect of Bacillus Velezensis DSM 33864 on the Reduction of Risk of Recurrent Clostridioides Difficile Infection (rCDI) in Adults With a History of rCDI
Trial No. NCT05606159
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Novozymes A/S
Contact: Victoria Oyedokun, PhD
+491723244702
EMAIL
Gender: All
Age: 18 Years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older